Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2005
09/01/2005US20050191312 Diagnosis by detecting overexpression; active or passive immunization; antibodies, transgenic animals, hybridoma
09/01/2005US20050191306 Cancerous disease modifying antibodies
09/01/2005US20050191305 Cancerous disease modifying antibodies
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191299 Identifying an inhibitor of CD70 by contacting a candidate CD70 inhibitor with a preparation of antigen presenting lamina propria (APCLP) cells; determining response of candidate inhbitor on gene expression of CD70 by said cells, and selecting an inhibitor; high throughput screening
09/01/2005US20050191294 Peptide that selectively binds IL-11 receptor-alpha (IL11R alpha ); prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer
09/01/2005US20050191291 Mixing biodegradable devices with T-cells so that one or more agents crosslink with the T-cell surface moieties and deliver a signal to enhance immunostimulatory capabilities;
09/01/2005US20050191290 Cell with immunoglobulin-free light chain (Ig-LC) receptor capable of activating signal transduction pathway upon binding to receptor; mast cell is activated and stimulated to degranulate; skin disorders, asthma, psoriasis, inflammatory bowel disease, rheumatoid arthritis, lupus, Sjogren*s syndrome
09/01/2005US20050191284 Which lack potential to differentiate into myeloid and erythroid lineages; interleukins; stem cell factors; natural killer cells
09/01/2005US20050191282 In polyvinylpyrrolidone cryoprotectant medium
09/01/2005US20050191281 Tissue graft
09/01/2005US20050191280 Immune regulation
09/01/2005US20050191274 Contacting peripheral blood mononuclear cell population with an amount of rhesus or human CMV interleukin IL-10 to inhibit proliferation; antiinflammatory, antiallergen, and bronchodilator agents; rheumantic, skin, gastrointestinal, autoimmune, Grave*s, and Hashimoto*s diseases; multiple sclerosis,
09/01/2005US20050189297 Introducing sample into remover unit comprising cross-flow chamber, subjecting sample to cross-flow parallel to filter having pore size of 1-10 microns, filtering, selectively removing non-stem cell constituents from sample to form cell population enriched for stem cells; preserves sterility, viability
09/01/2005DE10314363B4 Verfahren zur Simulierung humaner Blutzellen aus Tierblutzellen Method to simulate human blood cells from animal blood cells
09/01/2005DE102004007658A1 Verfahren zur Herstellung von rekombinanten Proteinen in eukaryontischen Wirtszellen A process for the production of recombinant proteins in eukaryotic host cells
09/01/2005CA2558685A1 Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle
09/01/2005CA2557595A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same
09/01/2005CA2557525A1 Cell/tissue culturing device, system and method
09/01/2005CA2557424A1 Methods for protein production
09/01/2005CA2556997A1 Methods for genetic diversification in gene conversion active cells
09/01/2005CA2556861A1 Protein ligands for nkg2d and ul16 receptors and uses thereof
09/01/2005CA2556418A1 Methods and materials using signaling probes
09/01/2005CA2556271A1 Use of indanoyl amide to stimulate secondary metabolism in taxus sp.
09/01/2005CA2556027A1 Monoclonal antibodies that specifically block biological activity of a tumor antigen
09/01/2005CA2555984A1 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
09/01/2005CA2555737A1 Schizochytrium fatty acid synthase (fas) and products and methods related thereto
09/01/2005CA2555417A1 Inhibition of fgf signaling
09/01/2005CA2555208A1 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
09/01/2005CA2554965A1 Antibodies specific for activated confirmation of lfa-1
09/01/2005CA2554691A1 Tissue system with undifferentiated stem cells derived from corneal limbus
09/01/2005CA2545591A1 Artificial synapse chip
08/2005
08/31/2005EP1568777A1 Deletion mutants from Neisseria glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
08/31/2005EP1568775A1 Cancer-associated gene
08/31/2005EP1568772A2 Human growth hormone variants
08/31/2005EP1568771A2 Human growth hormone variants
08/31/2005EP1568765A1 Method for genetic diversification in gene conversion active cells
08/31/2005EP1568708A2 Methods and medical uses of nucleic acids encoding a TRAF inhibitor
08/31/2005EP1568373A2 Inducing cellular immune responses to HER2/neu using peptide and nucleic acid compositions
08/31/2005EP1568273A1 METHOD OF CONSTRUCTING NONHUMAN MAMMAL HAVING RNAi PHENOTYPE
08/31/2005EP1567863A2 Methods of therapy and diagnosis
08/31/2005EP1567644A2 Tissue specific genes and gene clusters
08/31/2005EP1567639A2 Cultured human pancreatic islets, and uses thereof
08/31/2005EP1567539A2 Allele-specific rna interference
08/31/2005EP1567199A2 Neuroprotective activity of activated protein c is independent of its anticoagulant activity
08/31/2005EP1567196A2 Modulation of notch3 expression
08/31/2005EP1567190A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene
08/31/2005EP1567187A1 Proteins involved in the regulation of energy homeostasis
08/31/2005EP1567155A2 Administration of dendritic cells partially matured in vitro for the treatment of tumors
08/31/2005EP1567014A2 Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors
08/31/2005EP1567008A2 Protection of stem cells from cytotoxic agents by modulation of beta-catenin signaling pathways
08/31/2005EP1558738A4 Methods for regulating plant gaba production
08/31/2005EP1499710A4 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering
08/31/2005EP1484959A4 Nucleic acid constructs and methods for producing altered seed oil compositions
08/31/2005EP1463532A4 Dose response-based methods for identifying receptors having alterations in signaling
08/31/2005EP1395612B1 Modified recombinase
08/31/2005EP1379627A4 Method for differentiating mesenchymal stem cells into neural cells
08/31/2005EP1259264A4 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
08/31/2005EP1240168B1 Bicyclic inhibitors of glycogen synthase kinase 3
08/31/2005EP1238059A4 Long-term cell culture compositions and genetically modified animals derived therefrom
08/31/2005EP1235485A4 Lung stem cells and lung regeneration
08/31/2005EP1151085B1 Nucleic acid molecules encoding alternansucrase
08/31/2005EP1131456B1 Vectors for gene mutagenesis and gene discovery by gene trapping
08/31/2005EP1084250B1 Enzyme
08/31/2005EP1078064B1 Compounds from moraxella catarrhalis
08/31/2005EP0939653B1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
08/31/2005EP0786002B1 Intracellular isoform of the interleukin-1 receptor antagonist
08/31/2005CN1662649A Subtilases and subtilase variants having altered immunogenicity
08/31/2005CN1662645A Process for producing nerve cells
08/31/2005CN1662644A Method of producing human beta cell lines
08/31/2005CN1662643A Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
08/31/2005CN1662548A Regeneration of endogenous myocardial tissue by induction of neovascularization
08/31/2005CN1662254A ALCAM and ALCAM modulators
08/31/2005CN1662249A Osteopontin, oligodendrocytes and myelination
08/31/2005CN1661040A Method for screening drug resistant reversion agent for multiple drugs of treating tumors mediated by protein group of anti transportation
08/31/2005CN1661022A Method for producing material of transgenic plant in use for preventing bowel complaint babies
08/31/2005CN1661021A High performance genetic transformation method of regeneration system through mediated by agrobacterium tumefaciens for embryo tip soybean
08/31/2005CN1661011A Derivative growth factor of recombined human blood platelet, coded genes and expression method
08/31/2005CN1661010A Method for inducing fibroblast to form cartilage cells
08/31/2005CN1661009A Product of transegenic plant for expressing coat protein of human rotavirus and application for preventing infant diarrhea
08/31/2005CN1660913A Immunoassays for anti-HCV antibodies
08/31/2005CN1659959A Method for preparing and producing tissue type activator of plasminogen from mutant of transgene goat by nuclear transplantation
08/31/2005CN1659955A Method for obtainning plant of embryo sac of melon and dedicated culture medium
08/31/2005CN1216997C Cotton fiber reversible glycosylated proteinase gene and protein coded therewith
08/31/2005CN1216994C Use of Nicotianamine synthetase gene and method of raising plant antireverse property throughl transgenic plant
08/31/2005CN1216909C Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method
08/31/2005CN1216641C Monoclonal human matural antibodies
08/30/2005US6936752 Variety does well in Phytophthora and Soybean Cyst Nematode infected soils; Frogeye Leaf Spot resistance and glyphosate resistance; homozygous
08/30/2005US6936747 Methods for the replacement, translocation and stacking of DNA in eukaryotic genomes
08/30/2005US6936728 Production of hydroxylated fatty acids in genetically modified plants
08/30/2005US6936708 Expression of Alfin 1 and methods for producing transgenic plants having increased root growth and root specific gene activation
08/30/2005US6936705 nucleic acid sequence that is an insert of a clone selected from the group consisting of: yeast artificial chromosome, isolable from a transformant identified by international deposit number FERM BP-4271; BP-4273; BP-4274
08/30/2005US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
08/30/2005US6936701 Glycoconjugates and methods
08/30/2005US6936698 Genetically engineered immunoglobulin; for use in treatment of hematopoietic defects
08/30/2005US6936692 Binding antibodies; culture product; gene therapy; chromosome mapping
08/30/2005US6936691 Secreted protein HCE3C63
08/30/2005US6936688 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent
08/30/2005US6936457 DNA ENCODING HUMAN α AND β SUBUNITS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR, CELLS TRANSFORMED THEREWITH, AND RECOMBINANT CELL LINE EXPRESSING A HUMAN α AND β SUBUNIT OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR
08/30/2005US6936453 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
1 ... 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 ... 1827